CytomX Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.67	38.05	17.17	193.65	205.53
Short-Term Investments	124.39	62.57	157.34	-	99.7
Cash & Short-Term Investments	137.05	100.62	174.51	193.65	305.23
Cash Growth	36.20%	-42.34%	-9.88%	-36.55%	-3.45%
Accounts Receivable	2.01	3.1	3.43	35.99	0.79
Other Current Assets	4.86	3.58	5	7.47	4.29
Total Current Assets	143.92	107.31	182.94	237.1	310.3
Net Property, Plant & Equipment	4.7	10.6	16.18	21.02	25.32
Other Intangible Assets	0.44	0.58	0.73	0.88	1.02
Goodwill	0.95	0.95	0.95	0.95	0.95
Other Long-Term Assets	1.56	1.09	1	0.94	1.82
Total Assets	151.57	120.53	201.79	260.89	339.41
Accounts Payable	1.3	1.09	1.46	2.81	2.82
Accrued Expenses	14.2	12.34	17.6	24.45	34.24
Current Portion of Leases	4.24	5.15	4.59	4.08	-
Unearned Revenue	26.88	67.2	132.27	121.27	40.82
Total Current Liabilities	46.62	85.77	155.91	152.61	77.87
Long-Term Leases	-	4.24	9.39	13.98	18.06
Other Long-Term Liabilities	5.94	30.98	83.94	180.06	243.94
Total Long-Term Liabilities	5.94	35.22	93.33	194.03	262
Total Liabilities	52.56	120.99	249.24	346.64	339.87
Common Stock	0	0	0	0	0
Additional Paid-in Capital	810.84	691.1	675.91	637.12	623.34
Accumulated Other Comprehensive Income	0.11	0.03	0.1	0.01	-0.24
Retained Earnings	-711.95	-691.58	-723.45	-722.88	-623.56
Shareholders' Equity	99.01	-0.46	-47.45	-85.75	-0.46
Total Liabilities & Equity	151.57	120.53	201.79	260.89	339.41
Total Debt	4.24	9.39	13.97	18.06	18.06
Net Cash (Debt)	132.81	91.24	160.54	175.59	287.17
Net Cash Growth	45.57%	-43.17%	-8.58%	-38.85%	-2.47%
Net Cash Per Share	0.96	1.08	2.17	2.67	4.48
Book Value	99.01	-0.46	-47.45	-85.75	-0.46
Book Value Per Share	0.72	-0.01	-0.64	-1.30	-0.01
Tangible Book Value	97.62	-1.99	-49.13	-87.58	-2.43
Tangible Book Value Per Share	0.71	-0.02	-0.67	-1.33	-0.04

Updated Mar 16, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q